Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan · Delayed Price · Currency is TWD 70.40
+0.50 (0.72%)
Aug 7, 2026, 1:30 PM CST
Excelsior Medical Market Cap
Excelsior Medical has a market cap or net worth of 13.26 billion as of August 7, 2026. Its market cap has decreased by -4.86% in one year.
Market Cap
13.26B
Enterprise Value
13.07B
Revenue
8.98B
Ranking
n/a
PE Ratio
15.27
Stock Price
70.40
ChartMarket Cap Chart
Since July 3, 2003, Excelsior Medical's market cap has increased from 2.50B to 13.26B, an increase of 430.68%. That is a compound annual growth rate of 7.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 13.26B | -5.28% |
| Dec 31, 2025 | 14.00B | -0.37% |
| Dec 31, 2024 | 14.05B | 2.15% |
| Dec 29, 2023 | 13.76B | 37.31% |
| Dec 30, 2022 | 10.02B | 23.23% |
| Dec 30, 2021 | 8.13B | 2.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 550.34B |
| Caliway Biopharmaceuticals | 168.87B |
| Pell Bio-Med Technology | 62.07B |
| Lin BioScience | 58.31B |
| EirGenix | 14.74B |
| YungShin Global Holding | 14.06B |
| Grape King Bio | 13.14B |
| Foresee Pharmaceuticals | 12.56B |